共 6 条
- [1] The plant-based substance TOTUM-63 reduces fasting plasma glucose and HbA1c in people with prediabetes or type 2 diabetes: a 24-week, 600-people randomised controlled trial (REVERSE-IT)DIABETOLOGIA, 2024, 67 : S334 - S334Otero, Y. F.Sirvent, P.Johansen, O.Chavanelle, V.Sapone, V.Bouchard-Mercier, A.Boisseau, N.Cazaubiel, M.Pereira, B.Guigas, B.Peltier, S.Bard, J. -M.Woerle, H. -J.Hadjadj, S.Marette, A.
- [2] Baseline Characteristics in the REVERSE-IT Study, a 24-Week, 600-Person Randomized Placebo-Controlled Study of the Metabolic Effects of the Combination of Five Plant Extracts TOTUM-63 (T63)DIABETES, 2023, 72Otero, Yolanda F.Sirvent, PascalJohansen, Odd ErikChavanelle, VivienBargetto, MaximeSapone, VeroniqueBouchard-Mercier, AnnieLe Joubioux, FlorianBoisseau, NathalieMaugard, ThierryCazaubiel, MuriellePereira, BrunoGuigas, BrunoHadjadj, SamyPeltier, SebastienMarette, AndreBard, Jean-Marie
- [3] TOTUM-63, a plant-based polyphenol-rich extract, improves glycaemic control in subjects with prediabetes or early stage newly-diagnosed type 2 diabetes in a randomized, double-blind, placebo-controlled trialDIABETES OBESITY & METABOLISM, 2022, 24 (12): : 2331 - 2340Sirvent, PascalChavanelle, VivienOtero, Yolanda F.Bargetto, MaximeLe Joubioux, FlorianBoisseau, NathalieMaugard, ThierryCazaubiel, MuriellePereira, BrunoGuigas, BrunoHadjadj, SamyPeltier, Sebastien L.Marette, AndreBard, Jean-Marie
- [5] A Target HbA1c Between 7 and 7.7% Reduces Microvascular and Macrovascular Events in T2D Regardless of Duration of Diabetes: a Meta-Analysis of Randomized Controlled TrialsDiabetes Therapy, 2021, 12 : 1661 - 1676Binayak SinhaSamit Ghosal
- [6] Plasma glucose monitoring and the subsequent HbA1c control in patients with type 2 diabetes on a basal supported oral therapy regimen in real life: subanalysis of the ALOHA study: a 24-week, prospective, open-label, multicenter, observational studyDiabetology International, 2015, 6 (1) : 66 - 76Odawara M.Kadowaki T.Naito Y.